Prime Medicine PRME
NASDAQ PRME
$4.30 +0.40 (+10.26%)
At close: Nov 11, 2026 · 4:00 PM EST

Prime Medicine (PRME) Share-based Compensation (2021 - 2026)

Updated

Prime Medicine (PRME) posted Share-based Compensation of $4.87 million for Q2 2026, down 23.1% from $6.33 million a year earlier but up 4.8% from the prior quarter.

Analysis

Prime Medicine (PRME) Share-based Compensation (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Prime Medicine was $26.77 million, up 8.1% year-over-year; for FY2025, it came in at $29.27 million, up 12.3% from FY2024.

  • Annual Share-based Compensation has increased for five consecutive years, with a five-year compound annual growth rate of 137.1% (FY2020 to FY2025).
  • In prior years, Prime Medicine's Share-based Compensation was $26.07 million in FY2024 (+87.4%), $13.91 million in FY2023 (+115.4%), $6.46 million in FY2022 (+269.9%) and $1.75 million in FY2021 (+346.5%).
  • Quarterly Share-based Compensation has run from a low of $1.11 million in Q4 2021 to a high of $12.75 million in Q3 2025 over five years.
  • On a year-over-year basis, Share-based Compensation has declined in each of the last three quarters, with growth averaging 13.1% over the last eight quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q1 2024, with growth of 209.9%; the weakest was Q4 2025, with a decline of 24.0%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $4.64 million (Q1 2026), $4.52 million (Q4 2025) and $12.75 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 357.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 160.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 234.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 362.00 Mn
10 Prime Medicine 704.88 Mn 469.45 Mn - 4.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.87 Mn
Mar 31, 2026 4.64 Mn
Jun 30, 2025 6.33 Mn
Mar 31, 2025 5.68 Mn
Dec 31, 2024 5.94 Mn
Sep 30, 2024 6.83 Mn
Jun 30, 2024 8.09 Mn
Mar 31, 2024 5.21 Mn
Dec 31, 2023 4.43 Mn
Sep 30, 2023 4.22 Mn
Jun 30, 2023 3.58 Mn
Mar 31, 2023 1.68 Mn
Dec 31, 2022 2.57 Mn
Sep 30, 2022 1.42 Mn
Jun 30, 2022 1.35 Mn
Mar 31, 2022 1.12 Mn
Dec 31, 2021 1.11 Mn
API Access

Prime Medicine Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PRME&period=max&api_key=YOUR_API_KEY